Adverse Childhood Experiences Common in Schizophrenia
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 20, 2023 -- Patients with schizophrenia often have adverse childhood experiences (ACEs), according to a study published online Aug. 28 in Frontiers in Psychiatry.
Lei Zhang, Ph.D., from Tongji University in Shanghai, and colleagues examined the frequency and distribution of ACEs among patients with schizophrenia in a cross-sectional study involving 571 patients with schizophrenia. The Positive and Negative Symptoms Scale was used to assess symptomatology, and the Personality Diagnostic Questionnaire Fourth Edition Plus was used to assess personality pathology.
The researchers found that ACEs were highly prevalent, with at least one ACE reported by 80.8 percent of patients with schizophrenia. Physical neglect, emotional neglect, and emotional abuse were the three most common types of ACE (69.8, 28.2, and 22.9 percent, respectively). Emotional abuse was significantly associated with personality disorder traits, while significant associations were seen for emotional and physical neglect with negative symptoms. Men, younger individuals, and those with a higher level of antisocial personality disorder traits more commonly reported a higher level of physical abuse. More severe negative symptoms were seen in association with higher levels of physical neglect.
"Future research should further explore the complex relationships among ACEs, psychotic symptoms, and personality pathology. Longitudinal studies can provide valuable insight into the trajectories and progression of these effects over time," the authors write. "Such knowledge could ultimately inform the development of more effective interventions and treatment approaches for patients with schizophrenia and history of ACEs."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.